drugset / Trial / NCT00174408
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective is to evaluate, if Genotonorm (Genotropin) increases linear growth in short children born SGA. Safety of the drug is a main objective as well. The growth promoting effect of two different dosages is compared. The effect of long-term treatment on final height is evaluated (according to several amendments)
Timeline
- Start
- 1990-03
- Primary completion
- —
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | — | — |
Indications
No indication recorded.